Broker's Call: Metropolis Healthcare (Buy)
JM Financial06-03-2023
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting in person with the Investors/Analysts (Participants) as per the details below. 1) Wednesday, 1st March 2023 - Ambit Healthcare Tour 2) Thursday, 2nd March 2023 - Investec Conference 3) Friday, 3rd March 2023 - BoFA Healthcare Tour Discussions will be based on publicly available information. Kindly note that changes may happen due to exigencies on the part of Participants/Host/Company01-03-2023
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We would like to inform you that the officials of the Company will be meeting to Investors/Analysts (Participants) on 23rd Feb, 2023 (In person meeting) by "Kotak Conference" as the Host of the meeting. Further, Discussions will be based on publicly available information. Kindly note that changes may happen due to exigencies on the part of Participants / Host / Company.20-02-2023
Buy Metropolis Healthcare; target of Rs 1720: YES Securities
YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1720 in its research report dated February 14, 2023.20-02-2023
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is in continuation to our letter bearing Reference No. MHL/Sec&Legal/2022-23/88 dated February 03, 2023. Please find enclosed herewith the transcript of Q3/FY 22-23 Conference Call (i.e. Post Earnings/Quarterly Call), as organized by JM Financial Institutional Securities Limited held on Monday, February 13, 2023 at 09:00 a.m. (IST) wherein the financial results of the Company for the quarter ended December 31, 2022, were discussed. The same has also been uploaded on the Company's website and can be accessed at http://www.metropolisindia.com/17-02-2023
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
This is in continuation to our letter bearing reference No: MHL/Sec&Legal/2022-23/88 dated February 03,2023, with respect to intimation of Earnings Call for the quarter ended December 31, 2022 and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. The audio recording of the Earnings call held today i.e on Monday, February 13,2023 at 09:00 am (IST) to discuss the Financials Results of Q3FY23 of the Company, is available on the Company's website under the below link: https://www.metropolisindia.com/newdata/Investors/Submission-to-Stock-Exchange/2022-23/Q3/Metropolis%20Q3FY23%20Earnings%20Call%20Audio.mp313-02-2023
Metropolis Healthcare Results Earnings Call for Q3FY23
Conference Call with Metropolis Healthcare Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.13-02-2023
Metropolis Healthcare declares dividend of 8 per share, PAT falls 12% in Q3
With a market valuation of Rs. 6,567.98 Cr., Metropolis Healthcare Ltd. is a mid-size company that engages in the healthcare industry.11-02-2023
Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Newspaper Publication
This is to inform you that the Company on Saturday, February 11, 2023 has published an extract of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 as approved by the Board of Directors in their Meeting held on Friday, February 10, 2023. Please find enclosed, the copy published in Free Press Journal (English) and Navshakti (Marathi).11-02-2023
Metropolis Healthcare Ltd - 542650 - Intimation Of Amendment In Code Of Fair Disclosure Of Unpublished Price Sensitive Information Policy Of The Company
This is to inform you that the Board of Directors at its Meeting held on Friday, February 10, 2023 has inter alia, considered and approved the amendments in the Code of Fair Disclosure of Unpublished Price Sensitive Information Policy ('Code of Fair Disclosure') of the Company. The said Code of Fair Disclosure is enclosed herewith and is also being hosted on the website of the Company, viz. www.metropolisindia.com11-02-2023